BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10489663)

  • 1. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia.
    Kourakata H; Takada T; Suzuki E; Enomoto K; Saito I; Taguchi Y; Tsukada H; Nakano M; Arakawa M
    Respirology; 1999 Sep; 4(3):223-8. PubMed ID: 10489663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of polymyositis/dermatomyositis with steroid-resistant interstitial lung disease.
    Takada T; Suzuki E; Nakano M; Kagamu H; Tsukada H; Hasegawa T; Satoh M; Haraguchi M; Ebe T; Arakawa M
    Intern Med; 1998 Aug; 37(8):669-73. PubMed ID: 9745852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia.
    Yura H; Sakamoto N; Satoh M; Ishimoto H; Hanaka T; Ito C; Hasegawa T; Tanaka S; Miyamura T; Nakashima S; Hara A; Kakugawa T; Oda K; Kido T; Obase Y; Ishimatsu Y; Yatera K; Kawakami A; Mukae H
    Respir Med; 2017 Nov; 132():189-194. PubMed ID: 29229096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor BV gene repertoire of lymphocytes in bronchoalveolar lavage fluid of polymyositis/dermatomyositis patients with interstitial pneumonitis.
    Chino Y; Murata H; Goto D; Matsumoto I; Tsutsumi A; Sakamoto T; Ohtsuka M; Sekisawa K; Ito S; Sumida T
    Int J Mol Med; 2006 Jan; 17(1):101-9. PubMed ID: 16328018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
    Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte subsets in lung tissues of interstitial pneumonia associated with untreated polymyositis/dermatomyositis.
    Yamadori I; Fujita J; Kajitani H; Bandoh S; Tokuda M; Ohtsuki Y; Yoshinouchi T; Okahara M; Yamaji Y; Tanimoto Y; Sato Y; Ishida T
    Rheumatol Int; 2001 Nov; 21(3):89-93. PubMed ID: 11765227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM.
    Takato H; Waseda Y; Watanabe S; Inuzuka K; Katayama N; Ichikawa Y; Yasui M; Fujimura M
    Respir Med; 2013 Jan; 107(1):128-33. PubMed ID: 23137883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis.
    Kurasawa K; Nawata Y; Takabayashi K; Kumano K; Kita Y; Takiguchi Y; Kuriyama T; Sueishi M; Saito Y; Iwamoto I
    Clin Exp Immunol; 2002 Sep; 129(3):541-8. PubMed ID: 12197897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment.
    Schnabel A; Reuter M; Biederer J; Richter C; Gross WL
    Semin Arthritis Rheum; 2003 Apr; 32(5):273-84. PubMed ID: 12701038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronological evaluation of the onset of histologically confirmed interstitial pneumonia associated with polymyositis/dermatomyositis.
    Yang Y; Fujita J; Tokuda M; Bandoh S; Ishida T
    Intern Med; 2002 Dec; 41(12):1135-41. PubMed ID: 12521202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory biomarkers in polymyositis/dermatomyositis patients with interstitial lung disease: a retrospective study.
    Zhao J; Guo XJ; Shi L
    Curr Med Res Opin; 2024 Jan; 40(1):113-122. PubMed ID: 37938089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of CCL18 in bronchoalveolar lavage fluid of connective tissue disease-associated interstitial lung disease].
    He XW; Luo QZ; Shang Y; Gao ZC
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(38):2976-2981. PubMed ID: 31607028
    [No Abstract]   [Full Text] [Related]  

  • 15. Bronchoalveolar lavage fluid cells in mixed connective tissue disease.
    Enomoto K; Takada T; Suzuki E; Ishida T; Moriyama H; Ooi H; Hasegawa T; Tsukada H; Nakano M; Gejyo F
    Respirology; 2003 Jun; 8(2):149-56. PubMed ID: 12753528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Risk Factors of Polymyositis and Dermatomyositis Combined with Interstitial Lung Disease in Patients Residing in the Northeast Sichuan Province of China.
    Li T; Tang ZY; Zhang QB; Xiao FN; Jian GL; Xie Y; Guo JW; Qing YF
    Curr Rheumatol Rev; 2023; 19(4):455-462. PubMed ID: 37005523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
    Wang PZ; Guan JL; Han XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
    Chen F; Shu XM; Wang DX; Xie Y; Wang GC
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
    Hozumi H; Fujisawa T; Enomoto N; Nakashima R; Enomoto Y; Suzuki Y; Kono M; Karayama M; Furuhashi K; Murakami A; Inui N; Nakamura Y; Mimori T; Suda T
    J Rheumatol; 2017 Sep; 44(9):1394-1401. PubMed ID: 28711881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.